SCHEMBL31103307

SCHEMBL31103307

CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(Cc5cccc(NC6CCC(=O)NC6=O)c5)CC4)cc3)c2C1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 14/20 0.62
▸ AURKB Q96GD4 8/20 0.62
▸ ABL1 P00519 4/20 0.62
▸ NTRK1 P04629 3/20 0.62
▸ RET P07949 3/20 0.62
▸ FGFR1 P11362 3/20 0.62
▸ LIMK1 P53667 3/20 0.62
▸ BCR P11274 3/20 0.62
▸ CDK2 P24941 3/20 0.62
▸ FLT3 P36888 3/20 0.62
▸ PLK4 O00444 2/20 0.62
▸ JAK2 O60674 2/20 0.62
▸ MAP4K4 O95819 2/20 0.62
▸ LCK P06239 2/20 0.62
▸ FYN P06241 2/20 0.62
▸ FES P07332 2/20 0.62
▸ LYN P07948 2/20 0.62
▸ SRC P12931 2/20 0.62
▸ PHKG2 P15735 2/20 0.62
▸ FER P16591 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31103127 0.96 AURKA (0.57) AURKAAURKBABL1NTRK1RET
SCHEMBL31100127 0.94 AURKA (0.65) AURKAAURKBABL1NTRK1RET
SCHEMBL31101501 0.90 AURKA (0.59) AURKAAURKBABL1NTRK1RET
SCHEMBL31100451 0.90 AURKA (0.60) AURKAAURKBABL1NTRK1RET
SCHEMBL31101436 0.90 AURKA (0.64) AURKAAURKBABL1NTRK1RET
SCHEMBL31101148 0.89 AURKA (0.64) AURKAAURKBABL1NTRK1RET
SCHEMBL31100685 0.87 AURKA (0.61) AURKAAURKBABL1NTRK1RET
SCHEMBL31101675 0.87 AURKA (0.60) AURKAAURKBABL1NTRK1RET
SCHEMBL31100910 0.86 AURKA (0.66) AURKAAURKBABL1NTRK1RET
SCHEMBL31100901 0.86 AURKA (0.68) AURKAAURKBABL1NTRK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678638-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-01-14 — — EP claimed
WO-2024188209-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-09-19 — — WO claimed
Send feedback